<html>
<head>
  <title>SARS-CoV-2 Spike protein (S) gene K417E literature reference collection</title>
  <link rel="stylesheet" href="constellations.css">
</head>
<body>
<h1><a href="front.html">SARS-CoV-2</a> <a href="S.html">Spike protein (S)</a> gene <span class="constellation">S:p.K417E</span> literature reference collection</h1>
<div class="effect_section"><h2 id="ACE2_receptor_binding_affinity">ACE2 receptor binding affinity</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Causes 2.4 fold decrease in KD value for antibody binding of P22A-1D1.<br/> (<a href="https://doi.org/10.1038/s41467-021-24514-w" class="lit_link">Zhang et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Causes no detectable change in KD value for antibody binding of P5A-1D2.<br/> (<a href="https://doi.org/10.1038/s41467-021-24514-w" class="lit_link">Zhang et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Causes 15.9 fold decrease in KD value for antibody binding of P5A-3C8.<br/> (<a href="https://doi.org/10.1038/s41467-021-24514-w" class="lit_link">Zhang et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Causes 10 fold decrease in KD value for antibody binding of P2C-1F11.<br/> (<a href="https://doi.org/10.1038/s41467-021-24514-w" class="lit_link">Zhang et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Causes 1.7 fold decrease in KD value of antibody binding of ACE2.<br/> (<a href="https://doi.org/10.1038/s41467-021-24514-w" class="lit_link">Zhang et al. (2021)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="antibody_epitope_effects">Antibody epitope effects</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> No detectable fold drop in IC50 of P22A-1D1.<br/> (<a href="https://doi.org/10.1038/s41467-021-24514-w" class="lit_link">Zhang et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> No detectable fold drop in IC50 of P5A-1D2.<br/> (<a href="https://doi.org/10.1038/s41467-021-24514-w" class="lit_link">Zhang et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> No detectable fold drop in IC50 of P5A-3C8.<br/> (<a href="https://doi.org/10.1038/s41467-021-24514-w" class="lit_link">Zhang et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> 1.3 fold drop in IC50 of P2C-1F11.<br/> (<a href="https://doi.org/10.1038/s41467-021-24514-w" class="lit_link">Zhang et al. (2021)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="monoclonal_antibody_serial_passage_escape">Monoclonal antibody serial passage escape</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Moderately effective mutant against this position in the RBD for moderately neutralizing COV2-2082 monoclonal antibody.<br/>Mildly effective mutant against this position in the RBD for moderately neutralizing COV2-2094 monoclonal antibody (<a href="https://doi.org/10.1016/j.chom.2020.11.007" class="lit_link">Greaney et al. (2020)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Escape mutation against monoclonal antibody LY-CoV016, with modest loss of ACE2 binding affinity.<br/> (<a href="https://doi.org/10.1101/2021.02.17.431683" class="lit_link">Starr et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> In vitro selection against class 1 (Spike 'up' conformation) monoclonal antibodies C614, C660, C664, C683, and to a lesser extent C678.<br/>In vitro selection against class 2 (Spike 'up' or 'down' conformation, RBD targeting) monoclonal antibody C653. (<a href="https://doi.org/10.1101/2021.01.15.426911" class="lit_link">Wang et al. (2021)</a>)</span></li>
</ul></div>
<div class="acknowledgement">Automatically generated using text2ui script and data from <a href="https://github.com/nodrogluap/pokay">Pokay</a></div>
</body>
</html>
